Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. (Q45915574)
Jump to navigation
Jump to search
scientific article published on 30 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. |
scientific article published on 30 July 2009 |
Statements
1 reference
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. (English)
1 reference
Hartmut Döhner
1 reference
Thorsten Zenz
1 reference
Michael Hallek
1 reference
Sonja Häbe
1 reference
Tina Denzel
1 reference
Julia Mohr
1 reference
Dirk Winkler
1 reference
Andreas Bühler
1 reference
Antonio Sarno
1 reference
Silja Groner
1 reference
Raymonde Busch
1 reference
30 July 2009
1 reference
1 reference
114
1 reference
2589-2597
1 reference
13
1 reference
Identifiers
1 reference
1 reference